Evolent Health, Inc (EVH): Price and Financial Metrics

Evolent Health, Inc (EVH): $32.45

0.46 (+1.44%)

POWR Rating

Component Grades














  • Growth is the dimension where EVH ranks best; there it ranks ahead of 87.97% of US stocks.
  • The strongest trend for EVH is in Growth, which has been heading down over the past 177 days.
  • EVH's current lowest rank is in the Quality metric (where it is better than 15.8% of US stocks).

EVH Stock Summary

  • With a year-over-year growth in debt of 69.76%, EVOLENT HEALTH INC's debt growth rate surpasses 85.34% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, EVOLENT HEALTH INC is reporting a growth rate of 301.68%; that's higher than 95.1% of US stocks.
  • As for revenue growth, note that EVH's revenue has grown 48.91% over the past 12 months; that beats the revenue growth of 84.04% of US companies in our set.
  • Stocks that are quantitatively similar to EVH, based on their financial statements, market capitalization, and price volatility, are MMYT, LIND, CJJD, INOD, and AGL.
  • Visit EVH's SEC page to see the company's official filings. To visit the company's web site, go to www.evolenthealth.com.

EVH Valuation Summary

  • In comparison to the median Technology stock, EVH's price/sales ratio is 4% higher, now standing at 2.6.
  • EVH's price/sales ratio has moved NA NA over the prior 95 months.

Below are key valuation metrics over time for EVH.

Stock Date P/S P/B P/E EV/EBIT
EVH 2023-03-21 2.6 4.1 -182.5 -80.6
EVH 2023-03-20 2.6 4.0 -179.9 -79.5
EVH 2023-03-17 2.5 4.0 -178.5 -79.0
EVH 2023-03-16 2.6 4.1 -183.9 -81.2
EVH 2023-03-15 2.5 3.9 -175.5 -77.7
EVH 2023-03-14 2.5 4.0 -178.5 -79.0

EVH Growth Metrics

    The 5 year cash and equivalents growth rate now stands at -34.85%.
  • Its 5 year revenue growth rate is now at 188.1%.
  • The 5 year price growth rate now stands at -63.43%.
EVH's revenue has moved up $244,295,000 over the prior 15 months.

The table below shows EVH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,217.939 19.408 -13.462
2022-06-30 1,087.825 67.379 -28.625
2022-03-31 989.943 29.468 -33.144
2021-12-31 907.957 38.747 -37.601
2021-09-30 931.522 -40.76 -46.579
2021-06-30 973.644 -105.76 -70.887

EVH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • EVH has a Quality Grade of D, ranking ahead of 14.15% of graded US stocks.
  • EVH's asset turnover comes in at 0.713 -- ranking 221st of 563 Business Services stocks.
  • EVOL, GLOB, and AKAM are the stocks whose asset turnover ratios are most correlated with EVH.

The table below shows EVH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.713 0.254 -0.052
2021-06-30 0.726 0.244 -0.113
2021-03-31 0.742 0.245 -0.547
2020-12-31 0.746 0.228 -0.601
2020-09-30 0.704 0.220 -0.869
2020-06-30 0.636 0.223 -0.795

EVH Price Target

For more insight on analysts targets of EVH, see our EVH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $28.33 Average Broker Recommendation 1.43 (Moderate Buy)

EVH Stock Price Chart Interactive Chart >

Price chart for EVH

EVH Price/Volume Stats

Current price $32.45 52-week high $39.78
Prev. close $31.99 52-week low $21.83
Day low $32.14 Volume 972,500
Day high $32.68 Avg. volume 994,721
50-day MA $32.30 Dividend yield N/A
200-day MA $31.75 Market Cap 3.60B

Evolent Health, Inc (EVH) Company Bio

Evolent Health provides health-care delivery and payment solutions in the United States. The company was founded in 2011 and is based in Arlington, Virginia.

EVH Latest News Stream

Event/Time News Detail
Loading, please wait...

EVH Latest Social Stream

Loading social stream, please wait...

View Full EVH Social Stream

Latest EVH News From Around the Web

Below are the latest news stories about EVOLENT HEALTH INC that investors may wish to consider to help them evaluate EVH as an investment opportunity.

Evolent Health and Centene Agree to Expanded Partnership for Oncology Specialty Care for Medicare Advantage Members

Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, today announced an agreement to expand its Technology and Services solution for oncology with its existing partner, Centene Corporation, (NYSE: CNC).

Yahoo | March 29, 2023

Investors in Evolent Health (NYSE:EVH) have made a massive return of 443% over the past three years

Evolent Health, Inc. ( NYSE:EVH ) shareholders might be concerned after seeing the share price drop 12% in the last...

Yahoo | March 27, 2023

Evolent Health to Participate in Upcoming Conferences

Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Financial Officer John Johnson and Vice President, Investor Relations, Seth Frank will participate in upcoming investor conferences, including meetings with institutional investors and presentations.

Yahoo | March 3, 2023

Evolent Health Full Year 2022 Earnings: EPS Misses Expectations

Evolent Health ( NYSE:EVH ) Full Year 2022 Results Key Financial Results Revenue: US$1.35b (up 49% from FY 2021). Net...

Yahoo | February 24, 2023

Evolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth Outlook

Evolent Health Inc (NYSE: EVH) reported Q4 adjusted EPS of $0.10, missing the consensus of $0.16, compared to $0.08 a year ago. Revenues increased 54% Y/Y to $382.43 million, beating the consensus of $372.93 million. Total Lives on the Platform of 20.6 million as of Dec. 31, 2022, compared to 17.7 million a year ago. Total cases managed during the quarter within surgical management and advanced care planning totaled 15.7k, yielding an average per case revenue of $2.8k. Guidance: Evolent Health s

Yahoo | February 23, 2023

Read More 'EVH' Stories Here

EVH Price Returns

1-mo -7.97%
3-mo 15.56%
6-mo -9.69%
1-year 0.46%
3-year 497.61%
5-year 127.72%
YTD 15.56%
2022 1.48%
2021 72.61%
2020 77.13%
2019 -54.64%
2018 62.20%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.9406 seconds.